Chison Medical Technologies Co., Ltd. (688358.SS)
CNY 28.14
(0.32%)
CNY 28.14
(0.32%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 122.3 Million CNY | 3.75% |
| 2022 | 147.94 Million CNY | 7.78% |
| 2021 | 137.27 Million CNY | 31.25% |
| 2020 | 104.58 Million CNY | -6.54% |
| 2019 | 111.91 Million CNY | 19.33% |
| 2018 | 93.78 Million CNY | 12.19% |
| 2017 | 83.59 Million CNY | 17.44% |
| 2016 | 71.18 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 44.92 Million CNY | 28.1% |
| 2024 Q1 | 40.06 Million CNY | -5.57% |
| 2024 Q2 | 38.82 Million CNY | -3.1% |
| 2023 Q2 | 40.73 Million CNY | 6.51% |
| 2023 FY | 153.49 Million CNY | 3.75% |
| 2023 Q4 | 42.42 Million CNY | 32.23% |
| 2023 Q1 | 38.24 Million CNY | 15.58% |
| 2023 Q3 | 32.08 Million CNY | -21.22% |
| 2022 Q1 | 31.6 Million CNY | -19.87% |
| 2022 Q4 | 33.08 Million CNY | -22.73% |
| 2022 Q2 | 40.43 Million CNY | 27.93% |
| 2022 FY | 147.94 Million CNY | 7.78% |
| 2022 Q3 | 42.82 Million CNY | 5.9% |
| 2021 FY | 137.27 Million CNY | 31.25% |
| 2021 Q4 | 39.44 Million CNY | 8.88% |
| 2021 Q3 | 36.22 Million CNY | 11.58% |
| 2021 Q1 | 29.13 Million CNY | 13.66% |
| 2021 Q2 | 32.46 Million CNY | 11.45% |
| 2020 FY | 104.58 Million CNY | -6.54% |
| 2020 Q3 | 25.52 Million CNY | 8.25% |
| 2020 Q2 | 23.57 Million CNY | -21.02% |
| 2020 Q1 | 29.85 Million CNY | -12.39% |
| 2020 Q4 | 25.63 Million CNY | 0.43% |
| 2019 FY | 111.91 Million CNY | 19.33% |
| 2019 Q4 | 34.07 Million CNY | 35.09% |
| 2019 Q3 | 25.22 Million CNY | -15.33% |
| 2019 Q2 | 29.79 Million CNY | 30.61% |
| 2019 Q1 | 22.81 Million CNY | -6.84% |
| 2018 FY | 93.78 Million CNY | 12.19% |
| 2018 Q4 | 24.48 Million CNY | 0.0% |
| 2017 FY | 83.59 Million CNY | 17.44% |
| 2016 FY | 71.18 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Shenzhen Lifotronic Technology Co., Ltd. | 408.93 Million CNY | 70.091% |